- CA$41.30m
- CA$33.62m
- CA$89.81m
- 81
- 79
- 17
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 59.7 | 63.6 | 67.5 | 102 | 89.8 |
Cost of Revenue | |||||
Gross Profit | 33.9 | 33.5 | 29.9 | 45.7 | 41.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 62 | 69.5 | 79.3 | 112 | 96.4 |
Operating Profit | -2.35 | -5.95 | -11.7 | -10.3 | -6.62 |
Net Income Before Taxes | -2.35 | -5.95 | -11.7 | -10.3 | -6.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.9 | -5.76 | -11.6 | -9.09 | -7.23 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.9 | -5.76 | -11.6 | -9.09 | -7.23 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.9 | -5.76 | -11.6 | -9.09 | -7.23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.07 | -0.206 | -0.444 | -0.299 | -0.241 |
Dividends per Share |